TCTR20221029001尚未招募不适用
Therapeutic outcomes of Empiric Vancomycin in Febrile Neutropenia of Hematologic Malignancy Patients
/A0 个研究点目标入组 290 人开始时间: 2022年10月29日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 290
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1. Hematologic malignancy adult patients who admitted in Siriraj hospital
- •2. Diagnosed as febrile neutropenia as definition of IDSA 2010
排除标准
- •1. Trend to cannot evaluated outcome patient ex. palliative care, against advice
研究者
相似试验
招募中
不适用
Assessment of the risks and benefits of Vancomycin use in patients with infectioCritical patients, sepsis, acute kidney injury, dialysis, vancomycinC12.777.419.780.050D09.400.420.925C01.539.757E05.196.353RBR-4zrwtzDepartamento de Clínica Médica da Faculdade de Medicina de Botucatu
已完成
不适用
Vancomycin dosing in treatment of meningitispostneurosurgical meningitis.Pneumococcal meningitis, Streptococcal meningitisG00.1, G00IRCT2016071114693N6Shahid Beheshti University of Medical Sciences20
已完成
3 期
The comparison of vancomycin and teicoplanin in treatment of hospitalized children with severe pneumoniaPneumonia.Pneumonia, unspecifiedIRCT2015030111145N13Kashan University of Medical Sciences100
进行中（未招募）
不适用
Open pilot study of treatment with an antibiotic called vancomycin to children and adolescents with chronic inflammation of the bile ducts, called primary sclerosing cholangitis (PSC)EUCTR2009-018034-11-SEKarolinska Institutet20
尚未招募
2 期
Evaluation of vancomycin pharmacokinetics in patients with augmented renal clearanceIRCT20180802040665N1Shahid Beheshti University of Medical Sciences56